$1.05
▼ -1.4% Today
as of Jul 23, 13:15 ET
Last 30 days
Recent Press Releases & News
Artelo Biosciences Says New Data Shows ART26.12 Reduces Osteoarthritis Pain
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026
Overview
52-week range
$1.19
$86
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+2.1%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $4.00 | — | — | +655.6% | +1.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-3.97 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-5.61 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.72 | — | — | — | +3.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.52 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.78 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.83 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | — | -$16.83 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | — | $-3M | $-3M | $-2M | — | $-1M | $-3M |
| Net income | $-3M | — | $-3M | $-3M | $-2M | — | $-1M | $-2M |
| EPS (diluted) | $-4.00 | — | $-3.97 | $-5.61 | $-12.55 | — | $-2.10 | $-4.52 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $10M | $695,000 | $2M | $2M | $1M | $3M | $5M | $6M |
| Total assets | $13M | $3M | $4M | $4M | $4M | $5M | $7M | $8M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $4M | $5M | $6M | $3M | $2M | $775,000 | $1M |
| Total equity | $7M | $-1M | $-633,000 | $-1M | $652,000 | $3M | $6M | $7M |
Implied volatility — last 90 days
No IV snapshots yet for ARTL.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.